Cormorant Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-42,500
Closed -$4.15M 87
2015
Q1
$4.15M Sell
42,500
-57,500
-58% -$5.61M 0.64% 44
2014
Q4
$9.28M Hold
100,000
1.43% 23
2014
Q3
$6.88M Buy
+100,000
New +$6.88M 1.41% 18